Pelvic Area Extension Measurements for Four Types of Lumbopelvic Balance Using Three Different Methods (CRESPEOS)

Comparison and Reproducibility of Pelvic Area Extension Measurements for Four Types of Lumbopelvic Balance Using Three Different Methods: Clinical Observation Versus Photography Versus the EOS Imaging System

The main objective of this study is to describe for the first time the expansion reserve of the pelvic area (measurements using the EOS system) for each of the four morphotypes (Roussouly classification) commonly found in a population of healthy volunteers.

Study Overview

Detailed Description

Secondary objectives:

A. The intra-judge reproducibility and the interrater reliability for the different tools used to measure hip extension will be evaluated. Intra-judge reproducibility (photography) and interrater reliability (goniometry and photography) for the different tools used for measuring hip extension will be evaluated.

B. The concordance between EOS measurements and measurements acquired via goniometry and photography will be evaluated.

C. Describe certain radiographic measurements via the EOS system for the four morphotypes

Study Type

Observational

Enrollment (Actual)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • CHU de Montpellier - Hôpital Lapeyronie
      • Nîmes Cedex 9, France, 30029
        • CHU de Nimes - Hopital Universitaire Caremeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers 20 to 30 years of age.

Description

Inclusion Criteria:

  • The healthy volunteer must have given his/her informed and signed consent
  • The healthy volunteer must be insured or beneficiary of a health insurance plan

Exclusion Criteria:

  • The healthy volunteer is participating in another study
  • The healthy volunteer is in an exclusion period determined by a previous study
  • The healthy volunteer is under judicial protection, under tutorship or curatorship
  • The healthy volunteer refuses to sign the consent
  • It is impossible to correctly inform the healthy volunteer
  • The healthy volunteer is pregnant, parturient, or breastfeeding
  • The healthy volunteers had a history of chronic pain or surgery at the hip, the thoracolumbar spine or the sacroiliac area
  • The healthy volunteer has a hip, knee or ankle abnormality

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
The study population.

Healthy volunteers 20 to 40 years of age.

Intervention: Goniometric measure of pelvic extension reserve. Intervention: Photographic measure of pelvic extension reserve. Intervention: EOS measure of pelvic extension reserve.

The pelvic extension reserve (°) is measured via goniometry.

The goniometric measurements will be taken once by an investigator on all subjects and once by a different investigator on half of the subjects (with balanced distribution of morphotypes).

The pelvic extension reserve (°) is measured using photography.

Photographic measurements will be performed twice one investigator and 1 time by a different investigator (total of three measurements).

The pelvic extension reserve (°) is measured using the imaging system EOS.

Five X-rays will be made for each volunteer on the EOS system. The first is a frontal shot in a bipedal position, reference snapshot for verifying the absence of spinal deformity or hip pathology. The second and third are profile shots, one on the left and one on the right, whole body, bipedal position; serving as a reference picture. The fourth is profile shot, whole body, with the left hip in hyperextension. For maximum left hip hyperextension, the right leg rests on a step of varying height, and the hip is maximally flexed. The fifth is a profile shot, full body, with the right hip in hyperextension. For a maximum right hip hyperextension, the left leg rests on a step of varying height, and the hip is maximally flexed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EOS measurement of intrinsic reserve extension = angular variation of the sacral slope (left and right sides)
Time Frame: baseline (day 0)
= RIEeos
baseline (day 0)
EOS measurement of extrinsic extension reserve
Time Frame: Baseline (day 0)
= REEeos = angular variation of a specific angle (line joining the center of the sacral plate and the midpoint of the segment involving the center of the femoral head and the line joining this point to the top of the intercondylar knee notch) (left and right sides)
Baseline (day 0)
EOS measurement of global extension reserve
Time Frame: Baseline (day 0)
= RIEeos + REEeos (left and right sides)
Baseline (day 0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goniometric measurement of global extension reserve
Time Frame: baseline (day 0)
(left and right sides)
baseline (day 0)
Photographic measurement of global extension reserve
Time Frame: baseline (day 0)
(left and right sides)
baseline (day 0)
Roussouly classification: 1, 2, 3 or 4
Time Frame: baseline (day 0)
baseline (day 0)
Pelvic incidence (°)
Time Frame: Baseline (day 0)
Pelvic Incidence is defined as the angle between two lines: the line perpendicular to the sacral endplate at the middle of the sacral endplate to the line between the middle of the sacral endplate to the middle of the femoral heads.
Baseline (day 0)
Standing sacral slope at rest
Time Frame: Baseline (day 0)
Baseline (day 0)
Standing sacral slope in extension
Time Frame: Baseline (day 0)
Baseline (day 0)
Standing pelvic tilt at rest
Time Frame: Baseline (day 0)
Baseline (day 0)
Standing pelvic tilt in extension
Time Frame: Baseline (day 0)
Baseline (day 0)
Standing anterior pelvic plane
Time Frame: Baseline (day 0)
Baseline (day 0)
The front acetabular inclination while standing
Time Frame: Baseline (day 0)
Baseline (day 0)
The sagittal acetabular inclination while standing
Time Frame: Baseline (day 0)
Baseline (day 0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pascal Kouyoumdjian, MD, PhD, Centre Hospitalier Universitaire de Nîmes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

July 18, 2013

First Submitted That Met QC Criteria

July 24, 2013

First Posted (Estimate)

July 26, 2013

Study Record Updates

Last Update Posted (Estimate)

May 20, 2016

Last Update Submitted That Met QC Criteria

May 19, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • AOI/2012/PK
  • 2013-A00232-43 (Other Identifier: RCB number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteer

Clinical Trials on Goniometric measure of pelvic extension reserve.

3
Subscribe